✦ LIBER ✦

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

✍ Scribed by Baden, L. R.; Walsh, S. R.; Seaman, M. S.; Tucker, R. P.; Krause, K. H.; Patel, A.; Johnson, J. A.; Kleinjan, J.; Yanosick, K. E.; Perry, J.; Zablowsky, E.; Abbink, P.; Peter, L.; Iampietro, M. J.; Cheung, A.; Pau, M. G.; Weijtens, M.; Goudsmit, J.; Swann, E.; Wolff, M.; Loblein, H.; Dolin, R.; Barouch, D. H.

Book ID: 118056007
Publisher: University of Chicago Press
Year: 2012
Tongue: English
Weight: 767 KB
Volume: 207
Category: Article
ISSN: 0022-1899
DOI: 10.1093/infdis/jis670

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of Humoral and Cellular

Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)

✍ Barouch, D. H.; Liu, J.; Peter, L.; Abbink, P.; Iampietro, M. J.; Cheung, A.; Al 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 604 KB

First-in-Human Evaluation of a Hexon Chi

First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002)

✍ Baden, L. R.; Walsh, S. R.; Seaman, M. S.; Johnson, J. A.; Tucker, R. P.; Kleinj 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 573 KB

First-in-human phase 1 trial of the safe

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

✍ SR Walsh, MS Seaman, JA Johnson, RP Tucker, KH Krause, M Weijtens, MG Pau… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 65 KB

OA05-06 LB. First-in-human Phase 1 safet

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

✍ LR Baden, R Dolin, KL O'Brien, P Abbink, A La Porte, MS Seaman, E Choi… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 63 KB

Immunogenicity and Safety of the Quadriv

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

✍ Kojic, E. M.; Kang, M.; Cespedes, M. S.; Umbleja, T.; Godfrey, C.; Allen, R. T.; 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 426 KB

Phase 1 first-in-human studies of the re

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults

✍ Scott A. Halperin; Joanne M. Langley; Bruce Smith; Peter Wunderli; Lisa Kaufman; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB